Study: BPA Alternative Also Toxic
New research shows BPA replacement BPS disrupts hormones, is a "cause for concern."
Have you been reaching for products with the BPA-free label?
You may still be exposing yourself to hormone-disrupting chemicals, according to a first-of-its kind study on BPS (bisphenol S), a BPA (bisphenol A) alternative.
Consumer backlash over the health effects of BPA, including breast cancer, prostate cancer, reproductive defects and diabetes, led to a plethora of BPA-free products on shelves, while the European Union and the FDA banned its use in plastic bottles for infants.
But swapping out BPA for BPS may have meant "jumping from the frying pan to the fire."
A study published Thursday by Rene Vinas and Cheryl S. Watson of the University of Texas shows how low concentration ranges of BPS, the levels likely to be present in foods, are linked to the disruption of estrogen and are "cause for concern."
"People automatically think low doses do less than high doses," said lead author Watson, a University of Texas biochemistry professor. "But both natural hormones and unnatural ones like [BPS] can have effects at surprisingly low doses."
While BPS might not sound as familiar as BPA to many consumers, Environmental Health News says that BPS is everywhere:
In the past several years, BPS has replaced BPA in the printing of thermal paper used for cash register receipts. Every thermal receipt tested in a study published last year contained BPS. [...]
Nearly everyone worldwide is exposed to BPS. Eighty-one percent of urine samples from eight different countries contained traces of it, according to a study published last year. In comparison, about 93 percent of Americans have BPA in their urine. [...]
A lesser-known use for thermal paper is for ultrasound and other medical machine printouts. According to a 2012 report by the EPA, these BPA-free printouts largely contain BPS.
"I think we should all stop and be very cautious about just accepting [BPS] as a substitute for BPA," Watson said.
Environmental Working Group (EWG), a public health and environment watchdog, agrees. "We've long been concerned about Bisphenol S and the other bisphenol chemicals used in receipt paper and other consumer products. We urge EPA and the industry to carefully scrutinize these findings, and avoid jumping from the frying pan to the fire by replacing BPA with a similar looking and similarly toxic chemical," said EWG senior research analyst Sonya Lunder.
The study's findings also highlight the public health risk that comes with current chemical policy, Watson warns. "We should question the whole process about how we introduce chemicals into the marketplace without properly testing them first."
From the study:
BPS dramatically disrupted E2 [estradiol]-induced PRL [prolactin] release, as do other XEs [synthetic agents that can mimic and disrupt the actions of physiologic estrogens]. Disturbances in the timing or amount of PRL released can lead to a variety of physiologic complications including disruptions in electrolyte imbalance, growth and development, metabolic dysfunctions, behavioral disturbances, reproductive failure, or lactation failure. [...]
Our study is the first to demonstrate that the BPA-substitute BPS can induce rapid non-genomic signaling in estrogen-responsive pituitary cells at low (femtomolar-picomolar) concentrations. That BPS also interferes with physiologic E2 signaling leading to several functional endpoints is a cause for concern.
Read the whole study here.
Urgent. It's never been this bad.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission from the outset was simple. To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It’s never been this bad out there. And it’s never been this hard to keep us going. At the very moment Common Dreams is most needed and doing some of its best and most important work, the threats we face are intensifying. Right now, with just four days to go in our Spring Campaign, we are not even halfway to our goal. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Can you make a gift right now to make sure Common Dreams not only survives but thrives? There is no backup plan or rainy day fund. There is only you. —Craig Brown, Co-founder |
Have you been reaching for products with the BPA-free label?
You may still be exposing yourself to hormone-disrupting chemicals, according to a first-of-its kind study on BPS (bisphenol S), a BPA (bisphenol A) alternative.
Consumer backlash over the health effects of BPA, including breast cancer, prostate cancer, reproductive defects and diabetes, led to a plethora of BPA-free products on shelves, while the European Union and the FDA banned its use in plastic bottles for infants.
But swapping out BPA for BPS may have meant "jumping from the frying pan to the fire."
A study published Thursday by Rene Vinas and Cheryl S. Watson of the University of Texas shows how low concentration ranges of BPS, the levels likely to be present in foods, are linked to the disruption of estrogen and are "cause for concern."
"People automatically think low doses do less than high doses," said lead author Watson, a University of Texas biochemistry professor. "But both natural hormones and unnatural ones like [BPS] can have effects at surprisingly low doses."
While BPS might not sound as familiar as BPA to many consumers, Environmental Health News says that BPS is everywhere:
In the past several years, BPS has replaced BPA in the printing of thermal paper used for cash register receipts. Every thermal receipt tested in a study published last year contained BPS. [...]
Nearly everyone worldwide is exposed to BPS. Eighty-one percent of urine samples from eight different countries contained traces of it, according to a study published last year. In comparison, about 93 percent of Americans have BPA in their urine. [...]
A lesser-known use for thermal paper is for ultrasound and other medical machine printouts. According to a 2012 report by the EPA, these BPA-free printouts largely contain BPS.
"I think we should all stop and be very cautious about just accepting [BPS] as a substitute for BPA," Watson said.
Environmental Working Group (EWG), a public health and environment watchdog, agrees. "We've long been concerned about Bisphenol S and the other bisphenol chemicals used in receipt paper and other consumer products. We urge EPA and the industry to carefully scrutinize these findings, and avoid jumping from the frying pan to the fire by replacing BPA with a similar looking and similarly toxic chemical," said EWG senior research analyst Sonya Lunder.
The study's findings also highlight the public health risk that comes with current chemical policy, Watson warns. "We should question the whole process about how we introduce chemicals into the marketplace without properly testing them first."
From the study:
BPS dramatically disrupted E2 [estradiol]-induced PRL [prolactin] release, as do other XEs [synthetic agents that can mimic and disrupt the actions of physiologic estrogens]. Disturbances in the timing or amount of PRL released can lead to a variety of physiologic complications including disruptions in electrolyte imbalance, growth and development, metabolic dysfunctions, behavioral disturbances, reproductive failure, or lactation failure. [...]
Our study is the first to demonstrate that the BPA-substitute BPS can induce rapid non-genomic signaling in estrogen-responsive pituitary cells at low (femtomolar-picomolar) concentrations. That BPS also interferes with physiologic E2 signaling leading to several functional endpoints is a cause for concern.
Read the whole study here.
Have you been reaching for products with the BPA-free label?
You may still be exposing yourself to hormone-disrupting chemicals, according to a first-of-its kind study on BPS (bisphenol S), a BPA (bisphenol A) alternative.
Consumer backlash over the health effects of BPA, including breast cancer, prostate cancer, reproductive defects and diabetes, led to a plethora of BPA-free products on shelves, while the European Union and the FDA banned its use in plastic bottles for infants.
But swapping out BPA for BPS may have meant "jumping from the frying pan to the fire."
A study published Thursday by Rene Vinas and Cheryl S. Watson of the University of Texas shows how low concentration ranges of BPS, the levels likely to be present in foods, are linked to the disruption of estrogen and are "cause for concern."
"People automatically think low doses do less than high doses," said lead author Watson, a University of Texas biochemistry professor. "But both natural hormones and unnatural ones like [BPS] can have effects at surprisingly low doses."
While BPS might not sound as familiar as BPA to many consumers, Environmental Health News says that BPS is everywhere:
In the past several years, BPS has replaced BPA in the printing of thermal paper used for cash register receipts. Every thermal receipt tested in a study published last year contained BPS. [...]
Nearly everyone worldwide is exposed to BPS. Eighty-one percent of urine samples from eight different countries contained traces of it, according to a study published last year. In comparison, about 93 percent of Americans have BPA in their urine. [...]
A lesser-known use for thermal paper is for ultrasound and other medical machine printouts. According to a 2012 report by the EPA, these BPA-free printouts largely contain BPS.
"I think we should all stop and be very cautious about just accepting [BPS] as a substitute for BPA," Watson said.
Environmental Working Group (EWG), a public health and environment watchdog, agrees. "We've long been concerned about Bisphenol S and the other bisphenol chemicals used in receipt paper and other consumer products. We urge EPA and the industry to carefully scrutinize these findings, and avoid jumping from the frying pan to the fire by replacing BPA with a similar looking and similarly toxic chemical," said EWG senior research analyst Sonya Lunder.
The study's findings also highlight the public health risk that comes with current chemical policy, Watson warns. "We should question the whole process about how we introduce chemicals into the marketplace without properly testing them first."
From the study:
BPS dramatically disrupted E2 [estradiol]-induced PRL [prolactin] release, as do other XEs [synthetic agents that can mimic and disrupt the actions of physiologic estrogens]. Disturbances in the timing or amount of PRL released can lead to a variety of physiologic complications including disruptions in electrolyte imbalance, growth and development, metabolic dysfunctions, behavioral disturbances, reproductive failure, or lactation failure. [...]
Our study is the first to demonstrate that the BPA-substitute BPS can induce rapid non-genomic signaling in estrogen-responsive pituitary cells at low (femtomolar-picomolar) concentrations. That BPS also interferes with physiologic E2 signaling leading to several functional endpoints is a cause for concern.
Read the whole study here.